In this edition of STAT Health Tech: A new wave of blood pressure monitoring wearables, Stanford asking patients about AI, and more.
Vetenskapsnyheter
In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more.
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
Uganda closes its border, a Christian substitute for insurance, and more health news from Morning Rounds
Wearables with unvalidated blood pressure measuring tech are flooding the market after the FDA relaxed oversight of wellness devices.
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.
The public is about to get its first look at the prices of drugs launched since President Trump struck his most-favored-nation deals with 17 drugmakers.
An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.
A stem cell-based heart patch improved pumping in a small trial for advanced heart failure. "Very good first step," researcher says.
“This erosion of our strength is a loss for the nation,” writes MIT President Sally Kornbluth.
The business of living forever, Chan Zuckerberg Biohub's AI protein model, and other biotech news from The Readout
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel voted against the drug
In this edition of AI Prognosis, Brittany Trang takes a look at patients' role in how Stanford Health Care adopts AI tools, and more health AI news.
The conference where death is (theoretically) optional, new trends among undocumented patients, and more health news from Morning Rounds
If you've been vaccinated against Covid-19, some patients might not want your donated blood.
“Science itself is inherently resilient — that is, after all, why it’s science,” writes Jonathan Jackson.
“Trump has willingly exposed an entire generation of children to Big Tobacco’s nicotine addiction,” writes Sen. Dick Durbin.
Stanford Health Care started asking patients about new AI tools before they are implemented. Here's what patients are telling them.
Inside the longevity conference that brings together founders, investors, biohackers, and the generally death-averse to discuss how to forestall — or even beat — our demise.
Kyle Diamantas doesn't have the typical CV for an FDA commissioner, but he's earning early praise.
Medicaid cuts stemming from Republicans' 2025 tax law are expected to be even bigger than forecast.
President Trump is getting a medical exam on Tuesday, putting his health under renewed public scrutiny after he has worked to dismiss concerns over his age and stamina.
In this edition of STAT Health Tech: Early data from a Utah pilot using AI to renew prescriptions, Oura files to go public, and more.
Eli Lilly spends more of its GLP-1 cash, Humira's masterclass in monopoly, and more updates from The Readout
Eli Lilly reported that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a Phase 1 clinical trial